Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
Guofeng Ma, Zhilei Zhang, Peng Li, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 111

Showing 51-75 of 111 citing articles:

Mitochondrial medicine: “from bench to bedside” 3PM-guided concept
Qianwen Shao, Marie Louise Ndzie Noah, Olga Golubnitschaja, et al.
The EPMA Journal (2025)
Open Access
The SLC38A5/SNAT5 amino acid transporter: from pathophysiology to pro-cancer roles in the tumor microenvironment
Giuseppe Taurino, Martina Chiu, Massimiliano G. Bianchi, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 2, pp. C550-C562
Closed Access | Times Cited: 10
Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities
Xihe Zhao, Kai Li, Mengyu Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114601-114601
Open Access | Times Cited: 9
Glutamine Deficiency Promotes Immune and Endothelial Cell Dysfunction in COVID-19
William Durante
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7593-7593
Open Access | Times Cited: 9
CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling
Ai Chen, Xiao Sun, Shan Xiao, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Glutamine metabolism prognostic index predicts tumour microenvironment characteristics and therapeutic efficacy in ovarian cancer
Lingling Gao, Zheng Wei, Feiquan Ying, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 3
ASCT2-mediated glutamine uptake of epithelial cells facilitates CCL5-induced T cell infiltration via ROS-STAT3 pathway in oral lichen planus
Jingyi Lu, Zhangci Su, Wei Li, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110216-110216
Closed Access | Times Cited: 7
Recommendations for Nutritional Supplementation in Pediatric Oncology: A Compilation of the Facts
Alexandra Podpeskar, Roman Crazzolara, Gabriele Kropshofer, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3239-3239
Open Access | Times Cited: 7
GLS and GOT2 as prognostic biomarkers associated with dendritic cell and immunotherapy response in breast cancer
Ruifang Yang, Shuo Cheng, Jie Xiao, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24163-e24163
Open Access | Times Cited: 2
Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes
Soohyun Choe, Woori Kwak, E. Kim, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 137-137
Open Access | Times Cited: 2
B cell trajectories influence cancer outcomes
Julie Tellier, Stephen L. Nutt
Science (2024) Vol. 384, Iss. 6695, pp. 510-511
Closed Access | Times Cited: 2
Apoptosis, a Metabolic “Head-to-Head” between Tumor and T Cells: Implications for Immunotherapy
Ornella Franzese, Pietro Ancona, Nicoletta Bianchi, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 924-924
Open Access | Times Cited: 2
Glutaminase - A potential target for cancer treatment
Anthony Josephine, Sureka Varalakshmi, Ashok Kumar Sekar, et al.
Biomedicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 2
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
Christoforos Vaxevanis, Michael Bachmann, Barbara Seliger
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009774-e009774
Open Access | Times Cited: 2
Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy
Lexin Wang, Xue Zhou, Haisheng Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment
Durre Aden, Niti Sureka, Samreen Zaheer, et al.
Immunology (2024)
Open Access | Times Cited: 2
myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment
Hongsheng Fang, Weixing Dai, Ruiqi Gu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
HPV16 E6 and E7 Oncoproteins Stimulate the Glutamine Pathway Maintaining Cell Proliferation in a SNAT1-Dependent Fashion
Yunuen Ortiz-Pedraza, J. Omar Muñoz-Bello, Lucio Antonio Ramos-Chávez, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 324-324
Open Access | Times Cited: 6
The pan-cancer landscape of glutamate and glutamine metabolism: A comprehensive bioinformatic analysis across 32 solid cancer types
Wenhua Xue, Kai Wu, Xiao‐Na Guo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166982-166982
Open Access | Times Cited: 6
Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
Yishi Xu, Yaqing Liu, Yi Ge, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Systematic analysis of glutamine metabolism family genes and exploration of the biological role of GPT in colorectal cancer
Weiqi Dai, Wenhui Mo, Wenqiang Xu, et al.
Aging (2023) Vol. 15, Iss. 21, pp. 11811-11830
Open Access | Times Cited: 5
Genetic estimation of correlations between circulating glutamine and cancer.
Kai Zhang, Hongjin Liang
PubMed (2023) Vol. 13, Iss. 12, pp. 6072-6089
Closed Access | Times Cited: 4
Pumilio RNA binding family member 1 deficiency activates anti-tumor immunity in hepatocellular carcinoma via restraining M2 macrophage polarization
Yang Yü, Gang Nie, yi-wei ren, et al.
Cell Cycle (2024) Vol. 23, Iss. 6, pp. 682-692
Open Access | Times Cited: 1
The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma
Shutian Guo, Xinmiao Wang, Yifan Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116906-116906
Open Access | Times Cited: 1
Glutamine and leukemia research: progress and clinical prospects
Zexin Wang, Miao Liu, Qiang Yang
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Scroll to top